[Buruli ulcer or Mycobacterium ulcerans infection].

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Médecine et maladies infectieuses

• Publication date

  2010-02-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.medmal.2009.08.021PMID 19796893
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans

  2009cited by this paper
• Association of HIV infection and Mycobacterium ulcerans disease in Benin

  2008cited by this paper
• Buruli ulcer: progress report, 2004-2008.

  2008cited by this paper
• First Cultivation and Characterization of Mycobacterium ulcerans from the Environment

  2008cited by this paper
• Distribution of Mycobacterium ulcerans in Buruli Ulcer Endemic and Non-Endemic Aquatic Sites in Ghana

  2008cited by this paper
• Mycobacterium ulcerans Disease, Peru

  2008cited by this paper
• A Booster Vaccination with Mycobacterium bovis BCG Does Not Increase the Protective Effect of the Vaccine against Experimental Mycobacterium ulcerans Infection in Mice

  2007cited by this paper
• Mycobacterium ulcerans in Mosquitoes Captured during Outbreak of Buruli Ulcer, Southeastern Australia

  2007cited by this paper
• Recent progress in integrated neglected tropical disease control.

  2007cited by this paper
• A Novel Mycolactone Toxin Obtained by Biosynthetic Engineering

  2007cited by this paper
• Promising Clinical Efficacy of Streptomycin-Rifampin Combination for Treatment of Buruli Ulcer (Mycobacterium ulcerans Disease)

  2007cited by this paper
• Risk Factors for Mycobacterium ulcerans Infection, Southeastern Australia

  2007cited by this paper
• Community‐based study on knowledge, attitude and practice on the mode of transmission, prevention and treatment of the Buruli ulcer in Ga West District, Ghana

  2007cited by this paper
• Development and Application of Two Multiplex Real-Time PCR Assays for the Detection of Mycobacterium ulcerans in Clinical and Environmental Samples

  2007cited by this paper
• Association between haemoglobin variants S and C and Mycobacterium ulcerans disease (Buruli ulcer): a case‐control study in Benin

  2007cited by this paper
• Risk Factors for Buruli Ulcer: A Case Control Study in Cameroon

  2007cited by this paper
• Impact of Mycobacterium ulcerans Biofilm on Transmissibility to Ecological Niches and Buruli Ulcer Pathogenesis

  2007cited by this paper
• “Mycobacterium ulcerans subsp. shinshuense” Isolated from a Skin Ulcer Lesion: Identification Based on 16S rRNA Gene Sequencing

  2007cited by this paper
• Protection against Mycobacterium ulcerans Lesion Development by Exposure to Aquatic Insect Saliva

  2007cited by this paper
• Control of neglected tropical diseases.

  2007cited by this paper
• VNTR analysis differentiates Mycobacterium ulcerans and IS2404 positive mycobacteria.

  2007cited by this paper
• Dry reagent-based polymerase chain reaction compared with other laboratory methods available for the diagnosis of Buruli ulcer disease.

  2007cited by this paper
• Consensus recommendations for the diagnosis, treatment and control of Mycobacterium ulcerans infection (Bairnsdale or Buruli ulcer) in Victoria, Australia

  2007cited by this paper
• Outcomes for Mycobacterium ulcerans infection with combined surgery and antibiotic therapy: findings from a south‐eastern Australian case series

  2007cited by this paper
• Mycobacterium ulcerans disease (Buruli ulcer) in a rural hospital in Bas-Congo, Democratic Republic of Congo, 2002-2004.

  2006cited by this paper
• Contiguous spread of Mycobacterium ulcerans in Buruli ulcer lesions analysed by histopathology and real‐time PCR quantification of mycobacterial DNA

  2006cited by this paper
• Globally Distributed Mycobacterial Fish Pathogens Produce a Novel Plasmid-Encoded Toxic Macrolide, Mycolactone F

  2006cited by this paper
• A stepwise approach to the laboratory diagnosis of Buruli ulcer disease

  2006cited by this paper
• The local immune response in ulcerative lesions of Buruli disease

  2006cited by this paper
• Risk Factors for Buruli Ulcer, Benin

  2006cited by this paper
• Curing Mycobacterium ulcerans Infection in Mice with a Combination of Rifampin-Streptomycin or Rifampin-Amikacin

  2006cited by this paper
• [Relapses after surgical treatment of Buruli ulcer in Africa].

  2006cited by this paper
• Les rechutes après traitement de l'ulcère de Buruli par la chirurgie en Afrique

  2006cited by this paper
• In Vitro and In Vivo Activities of Rifampin, Streptomycin, Amikacin, Moxifloxacin, R207910, Linezolid, and PA-824 against Mycobacterium ulcerans

  2006cited by this paper
• Buruli ulcers: an emerging health problem in Ghana.

  2006cited by this paper
• Buruli ulcer: emerging from obscurity.

  2006cited by this paper
• Mycobacterium ulcerans infection: control, diagnosis, and treatment.

  2006cited by this paper
• BCG vaccine effectiveness against Buruli ulcer: a case-control study in Benin.

  2006cited by this paper
• Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo

  2005cited by this paper
• [Distribution of Mycobacterium ulcerans (Buruli ulcer) in the district of Lalo in Benin].

  2005cited by this paper
• [Mycobacterium ulcerans disease (Buruli ulcer): surgical treatment of 102 cases in the Democratic Republic of Congo].

  2005cited by this paper
• Factors associated with functional limitations and subsequent employment or schooling in Buruli ulcer patients

  2005cited by this paper
• A Novel Mycolactone from a Clinical Isolate of Mycobacterium ulcerans Provides Evidence for Additional Toxin Heterogeneity as a Result of Specific Changes in the Modular Polyketide Synthase

  2005cited by this paper
• Aggressive multifocal Buruli ulcer with associated osteomyelitis in an HIV‐positive patient

  2005cited by this paper
• Structure elucidation of a novel family of mycolactone toxins from the frog pathogen Mycobacterium sp. MU128FXT by mass spectrometry.

  2005cited by this paper
• Distribution de l'infection à Mycobacterium ulcerans (Ulcère de Buruli) dans la commune de Lalo au Bénin

  2005cited by this paper
• Ulcère à Mycobacterium ulcerans : Prise en charge chirurgicale dans 102 observations en République Démocratique du Congo

  2005cited by this paper
• Efficacy of the Combination Rifampin-Streptomycin in Preventing Growth of Mycobacterium ulcerans in Early Lesions of Buruli Ulcer in Humans

  2005cited by this paper
• Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans.

  2004cited by this paper
• Mycobacterium bovis BCG Vaccination as Prophylaxis against Mycobacterium ulcerans Osteomyelitis in Buruli Ulcer Disease

  2004cited by this paper
• Evaluation of Decontamination Methods and Growth Media for Primary Isolation of Mycobacterium ulcerans from Surgical Specimens

  2004cited by this paper
• Schistosoma haematobium Infection and Buruli Ulcer

  2004cited by this paper
• One-tube cell lysis and DNA extraction procedure for PCR-based detection of Mycobacterium ulcerans in aquatic insects, molluscs and fish.

  2004cited by this paper
• Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity

  2004cited by this paper
• Aquatic Snails, Passive Hosts of Mycobacterium ulcerans

  2004cited by this paper
• Aquatic Plants Stimulate the Growth of and Biofilm Formation by Mycobacterium ulcerans in Axenic Culture and Harbor These Bacteria in the Environment

  2004cited by this paper
• Structure determination of mycolactone C via total synthesis.

  2004cited by this paper
• [Treatment of Buruli ulcer desease by excision and skin graft].

  2004cited by this paper
• Traitement de l’ulcère de Buruli par excision-greffe : à propos de 118 observations

  2004cited by this paper
• [Knowledge-attitudes-practices survey of the Songololo population (D.R. Congo) about Buruli ulcers].

  2004cited by this paper
• [Ecology and transmission of Mycobacterium ulcerans].

  2003cited by this paper
• Development and Application of Real-Time PCR Assay for Quantification of Mycobacterium ulcerans DNA

  2003cited by this paper
• Heterogeneity of Mycolactones Produced by Clinical Isolates of Mycobacterium ulcerans: Implications for Virulence

  2003cited by this paper
• Écologie et mode de transmission de Mycobacterium ulcerans

  2003cited by this paper
• Mycolactones and Mycobacterium ulcerans disease.

  2003cited by this paper
• Bactericidal Activity of Rifampin-Amikacin against Mycobacterium ulcerans in Mice

  2002cited by this paper
• Buruli Ulcer in Ghana: Results of a National Case Search

  2002cited by this paper
• Aquatic Insects as a Vector for Mycobacterium ulcerans

  2002cited by this paper
• The use of IS2404 restriction fragment length polymorphisms suggests the diversity of Mycobacterium ulcerans from different geographical areas.

  2001cited by this paper
• Complete structure of the mycolactones.

  2001cited by this paper
• Detection of Phospholipase C in Nontuberculous Mycobacteria and Its Possible Role in Hemolytic Activity

  2001cited by this paper
• First reported case of Mycobacterium ulcerans infection in a patient from China.

  2000cited by this paper
• In vitro activity of ciprofloxacin, sparfloxacin, ofloxacin, amikacin and rifampicin against Ghanaian isolates of Mycobacterium ulcerans.

  2000cited by this paper
• Identification of Mycobacterium ulcerans in the Environment from Regions in Southeast Australia in Which It Is Endemic with Sequence Capture-PCR

  2000cited by this paper
• A Mycobacterium ulcerans Toxin, Mycolactone, Causes Apoptosis in Guinea Pig Ulcers and Tissue Culture Cells

  2000cited by this paper
• Biochemical and Genetic Evidence for Phospholipase C Activity in Mycobacterium ulcerans

  2000cited by this paper
• Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence.

  1999cited by this paper
• Identification and Characterization of IS2404 and IS2606: Two Distinct Repeated Sequences for Detection of Mycobacterium ulcerans by PCR

  1999cited by this paper
• Insects in the transmission of Mycobacterium ulcerans infection.

  1999cited by this paper
• Mycobacterium ulcerans infection.

  1999cited by this paper
• Mycobacterium ulcerans infection in a child from angola: diagnosis by direct detection and culture

  1998cited by this paper
• Partial purification and characterization of biological effects of a lipid toxin produced by Mycobacterium ulcerans.

  1998cited by this paper
• In Vitro Susceptibility of Mycobacterium ulcerans to Clarithromycin

  1998cited by this paper
• Partial Purification and Characterization of Biological Effects of a Lipid Toxin Produced byMycobacterium ulcerans

  1998cited by this paper
• [Buruli ulcers in Burkina Faso: apropos of 6 cases].

  1998cited by this paper
• Development of a PCR assay for rapid diagnosis of Mycobacterium ulcerans infection

  1997cited by this paper
• Detection of Mycobacterium ulcerans in environmental samples during an outbreak of ulcerative disease

  1997cited by this paper
• [Buruli ulcers in rural areas of Bénin: management of 635 cases].

  1997cited by this paper
• A large localized outbreak of Mycobacterium ulcerans infection on a temperate southern Australian island

  1997cited by this paper
• The emergence of Mycobacterium ulcerans infection near Melbourne

  1996cited by this paper
• Mycobacterium ulcerans infection (Buruli ulcer): first reported patients in Togo

  1996cited by this paper
• Copyright © 1997, American Society for Microbiology Immunomagnetic Separation and PCR for Detection

  1996cited by this paper
• Emergence of Buruli ulcer disease in the Daloa region of Cote d'Ivoire.

  1995cited by this paper
• [Epidemiological and clinical aspects of Buruli ulcer in Ivory Coast. 124 recent cases].

  1993cited by this paper
• Treatment of Mycobacterium ulcerans infection by hyperbaric oxygenation.

  1975cited by this paper
• Letter: Levamisole in rheumatoid arthritis.

  1975cited by this paper
• Immunoglobulin M. Specific for Measles and Mumps in Multiple Sclerosis

  1971cited by this paper
• Epidemiology of Mycobacterium ulcerans infection (Buruli ulcer) at Kinyara, Uganda.

  1971cited by this paper
• Clinical features and treatment of pre-ulcerative Buruli lesions (Mycobacterium ulcerans infection). Report II of the Uganda Buruli Group.

  1970cited by this paper
• BCG vaccination against mycobacterium ulcerans infection (Buruli ulcer). First results of a trial in Uganda.

  1969cited by this paper

• Mycobacterium Ulcerans Ulcer: Current Trends in Antimicrobial Management and Reconstructive Surgical Strategies

  2025influential citation
• Mathematical modeling of Buruli ulcer in fuzzy environment: global stability analysis

  2025cites this paper
• Analysis of Agro‐Environmental and Geo‐Climatic Factors Influencing Buruli Ulcer in the Kimpese Health Zone in Kongo Central, Democratic Republic of Congo

  2025cites this paper
• Knowledge, attitude and practices of buruli ulcer among residents in Jasikan municipality of Ghana: an ethnographic study

  2025cites this paper
• Control measures for neglected tropical diseases: vaccine updates

  2025cites this paper
• Atypical Mycobacterium ulcerans Infection with Skip Lesions in a 68-Year-Old Male: A Rare Case and Comprehensive Literature Review

  2025cites this paper
• Antimicrobial resistant bacteria isolated from Buruli ulcer lesions in Ghana

  2025cites this paper
• Suspected Buruli ulcer cases in Tonkolili District, Sierra Leone– a prospective cohort study

  2025cites this paper
• Mathematical modeling of Buruli ulcer spread

  2025cites this paper
• Successful treatment with joint retention of Mycobacterium ulcerans prosthetic joint infection in a patient with rheumatoid arthritis

  2025cites this paper
• Exploring Mycolactone—The Unique Causative Toxin of Buruli Ulcer: Biosynthetic, Synthetic Pathways, Biomarker for Diagnosis, and Therapeutic Potential

  2024influential citation
• Public Health Interventions for Fractional Optimal Control of Buruli Ulcer

  2024cites this paper
• Leveraging wastewater-based epidemiology to monitor the spread of neglected tropical diseases in African communities

  2024cites this paper
• A Bibliometric Study on Buruli Ulcer Based on the Web of Science Database

  2023cites this paper
• Qualitative study of the stigma associated with the lived experiences of Buruli ulcer disease among patients in Nigeria

  2023cites this paper
• Pathogenesis of an experimental mycobacteriosis in an apple snail

  2023cites this paper
• Repurposing of statins for Buruli Ulcer treatment: antimicrobial activity against Mycobacterium ulcerans

  2023cites this paper
• Season of transmission of Ross River/Barmah Forest Virus and Mycobacterium ulcerans closely align in southeastern Australia, supporting mosquitoes as the vector of Buruli ulcer

  2023cites this paper
• Buruli ulcer – A neglected tropical disease in the Barwon region of Victoria, Australia: An emerging public health threat with local and national ramifications

  2023cites this paper
• A transmission chain linking Mycobacterium ulcerans with Aedes notoscriptus mosquitoes, possums and human Buruli ulcer cases in southeastern Australia

  2023cites this paper
• Importance of consultations using mobile teams in the screening and treatment of neglected tropical skin diseases in Benin

  2023cites this paper
• Mycolactone A vs. B: Does localization or association explain isomer-specific toxicity?

  2023cites this paper
• Neglected tropical diseases in Republic of Guinea: disease endemicity, case burden and the road towards the 2030 target

  2023cites this paper
• Evalutation of the Additional Kabat’s Method Versus Conventional Physiotherapy in the Rehabilitation of Buruli Ulcer Patients (BUP), with Functional Limitations in the District Hospital of Akonolinga, Cameroon

  2023cites this paper
• Modeling the Potential Impact of Community Health Volunteers in the Diagnosis and Treatment of Buruli Ulcer

  2023cites this paper
• Mycolactone A vs. B: Multiscale Simulations Reveal the Roles of Localization and Association in Isomer-Specific Toxicity

  2023cites this paper
• Identification of potential candidate vaccines against Mycobacterium ulcerans based on the major facilitator superfamily transporter protein

  2022cites this paper
• Therapeutic efficacy of rifalazil (KRM-1648) in a M. ulcerans-induced Buruli ulcer mouse model

  2022cites this paper
• BCG Vaccine—The Road Not Taken

  2022cites this paper
• (Part 2) Molecular characterization of Mycobacterium ulcerans DNA gyrase and identification of mutations reduced susceptibility to quinolones in vitro

  2022cites this paper
• A Systematic Review on Suitability of Molecular Techniques for Diagnosis and Research into Infectious Diseases of Concern in Resource-Limited Settings

  2022cites this paper
• Can Membrane Composition Traffic Toxins? Mycolactone and Preferential Membrane Interactions

  2022cites this paper
• Prevalence, clinical manifestations and co-infections of buruli ulcer in parts of Imo State, Nigeria

  2022cites this paper
• Integrated Management Strategies (Diagnosis, Treatment, and Wound Care Management) for Improved Clinical Outcomes of Buruli Ulcer in Ghana: A Retrospective Case Report in the Ga West Municipal Hospital, Amasaman

  2022cites this paper
• Molecular Characterization of Mycobacterium ulcerans DNA Gyrase and Identification of Mutations Reducing Susceptibility to Quinolones In Vitro

  2022cites this paper
• Characterization of the Molecular Lipophilicity of Mycolactones A/B and C, Infectious Factors of Mycobacterium ulcerans Agent of Buruli Ulcer

  2021cites this paper
• Evaluation of different DNA extraction methods and loop-mediated isothermal amplification primers for the detection of Mycobacterium ulcerans in clinical specimens

  2021cites this paper
• Mental health and quality of life burden in Buruli ulcer disease patients in Ghana

  2021cites this paper
• Molecular characterization of Mycobacterium ulcerans DNA gyrase and identification of mutations reduced susceptibility against quinolones in vitro

  2021cites this paper
• Neglected tropical diseases: an effective global response to local poverty-related disease priorities

  2020cites this paper
• Proteomics of Select Neglected Tropical Diseases.

  2020cites this paper
• Mapping suitability for Buruli ulcer at fine spatial scales across Africa: A modelling study

  2020cites this paper
• Cell-mediated and serology-based tests for Mycobacterium ulcerans disease: A systematic review and meta-analysis

  2020cites this paper
• Observer et comparer les points d’eau fréquentés en milieu villageois : vers une meilleure compréhension des mécanismes de transmission de la maladie de l’ulcère de Buruli au sud-est du Bénin

  2020cites this paper
• Barriers to Buruli ulcer treatment completion in the Ashanti and Central Regions, Ghana

  2020cites this paper
• Prevalence and Perceptions in the Management of Buruli Ulcer in Oguta Local Government Area of Imo State, Nigeria

  2020cites this paper
• Proposing BCG Vaccination for Mycobacterium avium ss. paratuberculosis (MAP) Associated Autoimmune Diseases

  2020cites this paper
• First Molecular Characterisation of Clinical Strains of Mycobacterium ulcerans in Togo (West Africa)

  2019influential citation
• Mapping the global distribution of Buruli ulcer: a systematic review with evidence consensus

  2019cites this paper
• Buruli ulcer treatment: Rate of surgical intervention differs highly between treatment centers in West Africa

  2019cites this paper
• Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls

  2019cites this paper
• Paradoxical reactions in Buruli ulcer after initiation of antibiotic therapy: Relationship to bacterial load

  2019cites this paper
• Ulcère de Buruli : Connaissance et Rôle des Plantes dans la Transmission de la Maladie dans Quatre Villages des Districts Sanitaires de Daloa et Bouaké (Côte d’Ivoire)

  2019cites this paper
• A bibliometric assessment of global publication output on Buruli ulcer during 2000-2017

  2019cites this paper
• Mycolactone Toxin Membrane Permeation: Atomistic versus Coarse-Grained MARTINI Simulations.

  2019cites this paper
• Disseminated Mycobacterium ulcerans Infection in Wild Grasscutters (Thryonomys swinderianus), Côte d'Ivoire.

  2019cites this paper
• Buruli Ulcer: a Review of the Current Knowledge

  2018cites this paper
• Mechanism of Mycolactone Toxin Membrane Permeation: Atomistic vs Coarse-Grained MARTINI Simulations

  2018cites this paper
• Epidemiology of Buruli ulcer cases and a potential screening test for exposure

  2018cites this paper
• Risk factors for Mycobacterium ulcerans infection (Buruli Ulcer) in Togo ─ a case-control study in Zio and Yoto districts of the maritime region

  2018cites this paper
• A protocol for culturing environmental strains of the Buruli ulcer agent, Mycobacterium ulcerans

  2018cites this paper
• Immune-evasion Strategies of Mycobacteria and Their Implications for the Protective Immune Response.

  2018cites this paper
• In Silico Screening of Isocitrate Lyase for Novel Anti-Buruli Ulcer Natural Products Originating from Africa

  2018cites this paper
• Perception and incidence of Buruli ulcer in Ogun State, South West Nigeria: intensive epidemiological survey and public health intervention recommended

  2018cites this paper
• Challenges associated with the treatment of Buruli ulcer

  2018cites this paper
• High-Dose Rifamycins Enable Shorter Oral Treatment in a Murine Model of Mycobacterium ulcerans Disease

  2018cites this paper
• Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans

  2017cites this paper
• Skin manifestations in HIV positive patients

  2017influential citation
• Buruli Ulcer: Review of a Neglected Skin Mycobacterial Disease

  2017cites this paper
• Environmental and Behavioral Drivers of Buruli Ulcer Disease in Selected Communities along the Densu River Basin of Ghana: A Case-Control Study

  2017cites this paper
• Chronic cutaneous mycobacterial ulcers due to Mycobacterium ulcerans (Buruli ulcer): the first indigenous case report from Jordan and a literature review.

  2017cites this paper
• Applying the One Health Concept to Mycobacterial Research – Overcoming Parochialism

  2017cites this paper
• Mycobacterium ulcerans infection (Buruli ulcer) in French Guiana, South America, 1969-2013: an epidemiological study.

  2017cites this paper
• Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay

  2017cites this paper
• Seasonal Pattern of Mycobacterium ulcerans, the Causative Agent of Buruli Ulcer, in the Environment in Ghana

  2017cites this paper
• Infiltrating leukocytes surround early Buruli ulcer lesions, but are unable to reach the mycolactone producing mycobacteria

  2017cites this paper
• Occurrence and Distribution of Mycobacterium Ulcerans along the Densu and Offin River Basins of Ghana

  2017cites this paper
• Substrate Specificity of the LipN Hydrolase from Mycobacterium ulcerans

  2016cites this paper
• Susceptibility Profiles of Mycobacterium ulcerans Isolates to Streptomycin and Rifampicin in Two Districts of the Eastern Region of Ghana

  2016cites this paper
• Clinical and Laboratory Diagnosis of Buruli Ulcer Disease: A Systematic Review

  2016cites this paper
• Bug or no bug: challenges in diagnosing cutaneous mycobacterial infections

  2016cites this paper
• Clinical Features of Spontaneous Partial Healing During Mycobacterium ulcerans Infection

  2016cites this paper
• FVB/N Mice Spontaneously Heal Ulcerative Lesions Induced by Mycobacterium ulcerans and Switch M. ulcerans into a Low Mycolactone Producer

  2016cites this paper
• Spatial Distribution of Mycobacterium ulcerans in Buruli Ulcer Lesions: Implications for Laboratory Diagnosis

  2016cites this paper
• Keim oder kein Keim: Herausforderungen bei der Diagnose mykobakterieller Infektionen der Haut

  2016cites this paper
• Chitin promotes Mycobacterium ulcerans growth.

  2016cites this paper
• Buruli Ulcer in Cameroon: The Development and Impact of the National Control Programme

  2016cites this paper
• Isolation of Nontuberculous Mycobacteria from the Environment of Ghanian Communities Where Buruli Ulcer Is Endemic

  2016cites this paper
• Genotyping and Treatment of Secondary Bacterial Infections among Buruli Ulcer Patients in the Amansie Central District of Ghana

  2016cites this paper
• Buruli ulcer in West Africa: Suffering beyond the wound

  2016cites this paper
• Analysis of Buruli Ulcer prevalence in Amansie West district : a geostatistical approach

  2016cites this paper
• Spontaneous Healing of Mycobacterium ulcerans Lesions in the Guinea Pig Model

  2015cites this paper
• Treatment Outcome of Patients with Buruli Ulcer Disease in Togo

  2015cites this paper
• Buruli Ulcer in South Western Nigeria: A Retrospective Cohort Study of Patients Treated in Benin

  2015cites this paper
• Spatial Analysis of Anthropogenic Landscape Disturbance and Buruli Ulcer Disease in Benin

  2015cites this paper
• General Overview on Nontuberculous Mycobacteria, Biofilms, and Human Infection

  2015cites this paper
• Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease

  2015cites this paper
• Antibiotics in ingested human blood affect the mosquito microbiota and capacity to transmit malaria

  2015cites this paper
• Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis.

  2015cites this paper
• Chronic Osteomyelitis in Adults

  2015cites this paper